HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Starting lipid lowering at 40-49 could cut 30-year ASCVD risk from 17% to 6-12%

Gokhan Can · Nov 20, 2023 · ♥ 5 reactions · 1 comments · original Facebook post
LDL, ApoB & lipid panelStatins
AI summary & key facts

Summarizes a 2020 Circulation modeling study of early versus delayed primary prevention. Treating people with high cholesterol in their 40s lowered projected 30-year cardiovascular risk much more than waiting 10-20 years, especially with non-HDL-C of 160 mg/dL or higher.

The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering (2020)

Conclusions:

Notes:

Paper · Circulation · 2020The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering.Conclusion: Substantial reduction in expected atherosclerotic cardiovascular disease risk in the next 30 years is achievable by intensive lipid lowering in individuals in their 40s and 50s with non-HDL-C ≥160 mg/dL. For many, the question of when to start lipid lowering might be more relevant than whether to start lipid lowering.ahajournals.org

Research cited

#ascvd#cholesterol#cardiovasculardisease#nonhdl#prevention#cardiovascular#exercise#diabetes
← newer: The longer the lower the better: lifelong LDL lowering and aolder: Video: why lowering LDL does not increase mortality →